Journal of Carcinogenesis & Mutagenesis

Nanomechanical signatures of oral submucous fibrosis in sub-epithelial connective tissue.

Status of salivary lipid peroxidation in oral cancer and precancer

An Evaluation of Clinical and Histopathological Aspects of Patients with Oral Submucous Fibrosis in the Background of Oral Squamous Cell Carcinoma

Malignant transformation of oral submucous fibrosis: overview of histopathological aspects

Evaluation of the diagnostic efficacy and spectrum of autofluorescence of benign, dysplastic and malignant lesions of the oral cavity using VELscope.

A Catalogue of Altered Salivary Proteins Secondary to Invasive Ductal Carcinoma: A Novel In Vivo Paradigm to Assess Breast Cancer Progression

Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy

Targeting histone deacetylase and NF?B signaling as a novel therapy for Mucoepidermoid Carcinomas

Current Concepts of Epigenetics and Its Role in Periodontitis

The crucial role of emilin 1 gene expression during progression of tumor growth

Enhanced Metastatic Potential in a 3D Tissue Scaffold toward a Comprehensive in Vitro Model for Breast Cancer Metastasis.

Identification of stromal ColX?1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer

Non-invasive optical estimate of tissue composition to differentiate malignant from benign breast lesions: A pilot study.

Type III Collagen Directs Stromal Organization and Limits Metastasis in a Murine Model of Breast Cancer.

Microenvironment complexity and matrix stiffness regulate breast cancer cell activity in a 3D in vitro model.

The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to ?v?5 integrin activation and TRAIL resistance in human lung cancer cells

Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy

STIM1 silencing inhibits the migration and invasion of A549 cells.

Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.